He soon set about recruiting a research team and – by the early war years – Florey, Ernst Chain and others had turned over the department to making penicillin and demonstrating how effective it could be against bacterial infections. Penicillin then seemed nothing short of miraculous, banishing many infectious diseases that were some of the leading killers of the time. Indeed the work of the Oxford team ushered in the modern age of antibiotics.
It is 70 years since Florey – together with Norman Heatley and Jim Kent – carried out a crucial experiment which showed the clear potential of penicillin for the first time. On the 25th May 1940, eight mice were infected with lethal doses of streptococci bacteria. Four of the mice were then given injections of penicillin. In the morning, the untreated mice were dead while those that had received penicillin survived for days to weeks.
70 years on, the Dunn School of Pathology in Oxford is once again building new laboratories and looking to recruit top researchers for three vacant professorships.
The new £30m building next to the original Dunn School buildings – the Oxford Molecular Pathology Institute (OMPI) – offers an opportunity for top scientists to come to a leading Oxford biomedical research department and set up fresh research investigating the biology underlying disease processes.
Whether or not there’s a parallel with Howard Florey’s first arrival in Oxford all that time ago, OxSciBlog can take this opportunity to look back at some of the historical successes of the Dunn School with Eric Sidebottom, who has become the unofficial historian of the department.
The Dunn School is established
Teaching of pathology began in Oxford in 1896, but a full Department of Pathology wasn’t established until the new century in 1901 with James Ritchie as head of department. On Ritchie’s departure to Edinburgh in 1907, the first professor of pathology was appointed: Georges Dreyer.
A windfall of £100,000 in 1922 changed things significantly. The money, given by trustees of funds left by a Scottish trader called Sir William Dunn, enabled a brand new building to be constructed. The newly built Dunn School with its stylish red brick frontage was one of the best equipped labs in the country, says Eric Sidebottom.
Dreyer made a number of advances during his time as professor of pathology. During WW1, he set up a standards lab for growing bacterial cultures which were used to immunise the troops against typhoid. Also during the war, he developed the first oxygen masks for pilots and in the 1920s he thought he’d developed a new TB vaccine. ‘But by the end he’d run out of steam,’ says Eric. ‘Howard Florey came to take over the department in 1935 to find wonderful labs, but it was largely empty space with little research funding.’
It was a close-run thing that Howard Florey ended up with the chair, Eric recounts. An electoral board had to decide on the appointment, and it had two influential external members: Sir Edward Mellanby, secretary of the Medical Research Council, and Sir Robert Muir, a Scottish pathologist.
Sidebottom says: ‘Mellanby was for Florey but Muir had an older, safer candidate in mind. Mellanby’s train broke down on the way to the board meeting that was to decide on the position. In his absence, the board decided to go for the safe pair of hands. But before the meeting ended, Mellanby arrived and persuaded them differently.’
The story of penicillin
Florey in short time recruited the German émigré chemist Ernst Chain from Cambridge. ‘It was Chain who rediscovered Fleming’s earlier paper on the antibacterial qualities of penicillin,’ says Eric.
Everyone associates Alexander Fleming with penicillin. It was in September 1928 at St Mary’s Hospital Medical School that he noticed stray mould growing on a plate of bacteria, and around the Penicillium mould was a clear area where the bacteria had been killed. He recognised the significance of the observation and set about identifying the antibacterial substance responsible, calling it ‘penicillin’. But he never went on to purify the substance or test it against bacterial infections in animals or humans.
Those large and vitally important steps required the vision, graft and dedication of Florey’s team in Oxford.
Florey and Chain began work on penicillin in 1939, says Eric. ‘They quickly confirmed Fleming’s findings and began to purify the substance.’ Here the contributions of another member of the team, Norman Heatley, were crucial. ‘Heatley had the technical vision necessary to purify penicillin,’ says Sidebottom. He devised a successful method for extracting and purifying penicillin from the cultures of mould grown in hundreds of vessels throughout the Dunn School labs. The automated process he came up with made use of bedpans, milk churns and baths all rigged together, yet it worked very well.
By the height of the blitz in May 1940 the team was at a point where they could carry out that crucial experiment in mice mentioned earlier. It would really test for the first time whether penicillin could be an effective antibacterial drug.
The results of the experiment were clear and impressive. But as Florey pointed out: ‘Treating and curing infections in mice was one thing, but humans are roughly 3000 times bigger and would need 3000 times more penicillin.’ As a result, the Dunn School was turned into a penicillin factory, production running 24 hours a day...
From mice to men
By February 1941, when Florey felt he had enough to begin trials in humans, he enlisted the help of a young doctor at the Radcliffe Infirmary in Oxford, Charles Fletcher. The first patient Albert Alexander, a 43-year-old policeman, was treated with penicillin on 12 February 1941.
The stories normally have it that Albert Alexander had scratched his face on a rose bush, the wound had become infected and the infection had spread. But Eric offers an alternative. He has an old police pamphlet of stories about individual officers which suggests Alexander was injured during a bombing raid while he was on secondment from Abingdon to Southampton. He was transferred to the Radcliffe Infirmary when his infection became severe. Frustratingly his hospital notes don’t reveal the cause of his infections.
Charles Fletcher injected Alexander with penicillin regularly over four days, and within 24 hours he was greatly improved. But even though the team went as far as extracting the precious penicillin from his urine and re-injecting it, supplies ran out before his cure was complete. He relapsed at the beginning of March, and died a month later.
Of the next seriously ill patients, four made recoveries thanks to penicillin. A child of four was also cured of his infection, but died of an unrelated brain haemorrhage.
Penicillin truly looked like a miracle drug: infections that had been killing people previously were cured. As companies in the US and UK began to take up manufacture of penicillin, enough was being produced to treat some of the military. Supplies accompanied the troops in the D-day landings and the death toll from infected wounds during the campaign was dramatically reduced.
Still, Eric Sidebottom suggests some sensitive decisions had to be made about how best to use what penicillin supplies there were: ‘In 1943, Florey and Chain travelled out to North Africa to oversee the use of penicillin to treat infected injuries. Penicillin was also found to be extremely effective in treating the clap (gonorrhoea). This presented the military with a problem: with limited supplies, which soldiers should receive the drug – those with clap or those with horrific injuries? Churchill reportedly decided to use it to “best military advantage” (give it those with the clap to get them back onto the front lines more quickly).’
So how did the greatest medical advance of the 20th century come to be solely linked to the name of Alexander Fleming in most people’s minds? After all, Fleming shared the Nobel Prize with Florey and Chain. And it was the Oxford team’s dedicated work that turned Fleming’s chance observations into a safe, effective drug capable of being manufactured on a large scale.
Eric has the answer: ‘When the potential of penicillin became clear in 1941 and 1942, St Mary’s Hospital realised what a coup it was going to be. The dean of St Mary’s, Charles Wilson (soon to be ennobled as Lord Moran), was also Churchill’s physician and president of the Royal College of Physicians. When he said, “We [St Mary’s] discovered it,” people listened. More than that, Lord Beaverbrook – the powerful press baron – was a patron of the hospital and was instrumental in setting the agenda in the press. In contrast to all the media attention Fleming was getting, Florey refused to speak to the press at all.’
The history of the Dunn School of Pathology didn’t begin and end with penicillin, of course.
Penicillin inspired worldwide efforts to discover new drugs that could conquer the many diseases still threatening the world. Further antibiotics soon followed, including streptomycin, chloramphenicol, the tetracyclines, and erythromycin. The Oxford team continued to work on this area and another important family of antibiotics, the cephalosporins, were developed from research by Edward Abraham and Guy Newton at the Dunn School. Proceeds from these patents continue to fund research around the University, and are paying for most of the cost of the new OMPI building at the Dunn School.
‘Florey’s other legacy was a world-class research programme in Oxford,’ says Eric. ‘For example, Sir Henry Harris and Sir James Gowans were two of Florey’s students.’ Together they did a lot of the foundation work that allowed the discovery of monoclonal antibodies by others later on, Eric says.
Gowans worked out the life cycle of lymphocytes – a type of white blood cell that is central to our immune responses and fighting off disease – and their recirculation, while Harris developed the experimental technique of artificial cell fusion. In addition to leading to the discovery of monoclonal antibodies, this led to new theories about how cancers become malignant and how the body suppresses tumours from forming.
This historical research focus on immunity, cell biology, and fighting infections is reflected in the research interests of the department today. Current research strengths include cancer cell biology, influenza and HIV, gene transcription and RNA processing, Alzheimer’s disease, stem cell biology, and regulation of immune responses.
Into the future
The new institute OMPI is being built next to the original 1920s Dunn School building and will house over 200 researchers.
With new appointees to three
vacant professorial chairs to add to the department’s existing
strengths, who knows where research in the state-of-the-art labs will
lead? Let’s hope it will add to Eric Sidebottom’s repertoire of stories
of research successes from the Dunn School.